Sep 04, 2024
Danaher Confirms Third Quarter and Full Year 2024 Guidance
Jul 23, 2024
Danaher Reports Second Quarter 2024 Results
Jul 11, 2024
Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening
Jun 24, 2024
Danaher Schedules Second Quarter 2024 Earnings Conference Call
Jun 05, 2024
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
May 09, 2024
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
May 07, 2024
Danaher to Present at Bank of America Securities Healthcare Conference
May 07, 2024
Danaher Announces Quarterly Dividend
Mar 21, 2024
Danaher Schedules First Quarter 2024 Earnings Conference Call
Feb 27, 2024
Danaher to Present at TD Cowen Health Care Conference
Feb 22, 2024
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
Feb 21, 2024
Danaher Announces Quarterly Dividend
Feb 05, 2024
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
Jan 30, 2024
Danaher Reports Fourth Quarter and Full Year 2023 Results
Jan 09, 2024
Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
Jan 08, 2024
Danaher CEO to Comment on Financial Performance
Feb 23, 2021
Danaher Announces Quarterly Dividends
Jan 28, 2021
Danaher Reports Fourth Quarter And Full Year 2020 Results
Jan 07, 2021
Danaher Schedules Fourth Quarter 2020 Earnings Conference Call
Dec 14, 2020
Danaher announces leadership appointment